Caricamento...
Mirtazapine-associated movement disorders: A literature review
Mirtazapine (MTZ) is an atypical antidepressant approved by the FDA, which mechanism of action involves the antagonism of alpha-2, H1, 5-HT2A, 5-HT2C, and 5-HT3 receptors. In this context, the aim of this literature review is to evaluate the clinical epidemiological profile, pathological mechanisms,...
Salvato in:
| Pubblicato in: | Tzu Chi Med J |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer - Medknow
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7605300/ https://ncbi.nlm.nih.gov/pubmed/33163376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tcmj.tcmj_13_20 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|